Pragmaxis LLC, a Dallas-based business strategy and technology commercialization consulting firm, announced today that its founder and managing director Peter Balbus will be a featured speaker at the nanoTX'07 conference.
JFE Steel Corp. announced the prototype of 1,180 MPa Class Nano Hiten, an ultrahigh tensile strength hot rolled steel plate with a 1,180-MPa class tensile strength and an excellent elongation property.
In our recent Spotlight on nanoparticle printing we wrote that "...for automated patterning of particles, existing methods are either slow (e.g., dip-pen lithography) or require prefabricated patterns on the target substrate...". This statement of course completely ignored the advanced and fast Dip Pen Nanolithography technology developed at NanoInk, Inc.
Clariant, a world leader in specialty chemicals and Schoeller Technologies AG, a globally active licensing company for innovative textile technologies, today announced a strategic partnership for the nanotechnology-based NanoSphere textile finish.
Nano Valley Consortium members include small and large companies, academics, and government agencies who work together to commercialize nano research for military and commercial applications. The Consortium Kick-Off Meeting is October 18th and 19th in Swainsboro, GA.for new and prospective members.
Keithley Instruments, Inc. announces two new additions to its Series 2600 SourceMeter™ Instruments to create the industry's most advanced and cost effective solution for semiconductor parametric analysis and testing.
NanoSmart is a strategic program for Europe, and will develop advanced substrates for microelectronic and optoelectronic components, spotlighting the significant role played in substrate engineering innovation.
Nanobac Pharmaceuticals Inc. and American Health Associates Clinical Laboratories have reached an agreement for AHA to serve as the exclusive U.S. provider of Nanobac proprietary blood tests that can detect blood levels of Calcifying Nanoparticles, which are found in coronary artery calcification, kidney stones, and other stone forming diseases.
iCeutica, Inc. announces nano-pharmaceuticals industry leader Dr. William Bosch has joined iCeutica, Inc. Until recently, Dr. Bosch was a senior member of the research and development management team at Elan Corporation responsible for Elan's NanoCrystal Technology and the related drug reformulation and delivery business.